Nya rön kring blåbär och cancer

Möss som fick blåbärsextrakt fördubblade sin livslängd och hade hälften så stora tumörer som möss i en kontrollgrupp. Det visar en ny amerikansk studie.

Hundar kan också få ALS

Forskare har identifierat en genmutation som orsakar amytrofisk lateralskleros hos flera hundraser. Samma gen ligger bakom samma sjukdom hos människor.

Euris avnoteras

Styrelsen har beslutat att lista om bolaget på en annan handelsplats, för att minska kraven på administration.

Forskningsstöd missgynnar kvinnor

Fler män får stöd, och de får i genomsnitt mer pengar. De danska forskningsrådens sätt att fördela pengar förstärker könsskillnaderna i forskningsvärlden, enligt en ny rapport.

Elekta säljer cancerteknik till Ryssland

Två ledande cancerkliniker i Moskva och Sibirien får Rysslands mest avancerade system för strålterapi.

Go ahead for leg wound study

Tripep starts a phase II-study of their wound healing joint venture project.

First ever study of human stem cell treatment

The FDA says yes to the world's first study in man of a human embryonic stem cell based therapy to treat spinal injury.

EU says yes to Roche drug

EU approves a first in class therapy for treatment of patients with moderate to severe form of rheumatoid arthritis.

Danisco strengthens its IP team

Danisco's division Genencor has appointed a new Vice President of Intellectual Property Strategy and Chief IP Counsel.

Finnish-Dutch engineering cooperation continues

The University of Helsinki and ASM International renew a fice year research agreement on Atomic Layer Deposition.

Dako appoints new CEO

The Danish cancer therapeutic company Dako has appointed a new CEO after Patrik Dahlén.

Swedish multi competent machine soon launched

The Swedish company Biosensor will launch new equipment able to detect twelve different narcotics and explosives simultaneously.

Finnish Innovation Fund gets new leader

The Supervisory Board of the Finnish Innovation Fund Sitra has appointed members of the Board, including a new president.

Pharma is a safe market

Pharma is the best industry to invest in. That states leaders from risk capital companies, interviewed by the Economist Intelligence Unit.

LEO Pharma - International Clinical Trial Manager

View pathology images in your iPhone

The Institute for Medical Informatics in Oslo announces a brand new iPhone application for virtual microscopy.

Norwegian entrance in EU technology network

The Norwegian University of Science and Technology joins the European Science Business Network of prominent European research institutions.

SDU professor helps EU

Mette Præst Knudsen from the University of Southern Denmark, SDU, has been appointed as an expert member in an EU politics group.

New CEO to Swedish Tillotts Pharma

The Swiss company Tillotts Pharma's newly established Swedish organisation has appointed a CEO from Bayer Scandinavia.

New faces in Pronova Biopharma team

The Norwegian company Pronova Biopharma has recently changed the management team structure.

EU grants project on toxicity of nanomaterials

A multinational research project has have been awarded EUR 3 358 500 from the European Commission to study the hazardous effects of engineered nanomaterials on the immune system.

New Nordic biotech company

The Swiss biotech company Tillots Pharma opens a office in Stockholm, which will be run under private management.

New tools to fight bacteria

Better guidelines for doctors, detailed patient journals, and national monitoring systems are some of the tools needed to combat the increasing problem of antibiotic-resistant bacteria. That is stated in a report commissioned by the Swedish government.

New management at Øresund

The Øresund University has recently appointed a new director and a new Chairman.